Author:
Srivastava Saumya,Gupta Anil Kumar,Sharma Pawan,Singh Amit
Publisher
Springer Nature Singapore
Reference35 articles.
1. Organization, World Health. Lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV: policy update (2019): evidence to decision tables. World Health Organization; 2019.
2. Global Tuberculosis Report 2022. n.d.; Accessed 23 Mar 2023. https://www.who.int/publications/i/item/9789240061729.
3. Marlowe EM, Novak-Weekley SM, Cumpio J, Sharp SE, Momeny MA, Babst A, Carlson JS, Kawamura M, Pandori M. Evaluation of the cepheid Xpert MTB/RIF assay for direct detection of mycobacterium tuberculosis complex in respiratory specimens. J Clin Microbiol. 2011;49(4):1621–3.
4. Chakravorty S, Simmons AM, Rowneki M, Parmar H, Cao Y, Ryan J, Banada PP, Deshpande S, Shenai S, Gall A. The new Xpert MTB/RIF ultra: improving detection of mycobacterium tuberculosis and resistance to Rifampin in an assay suitable for point-of-care testing. MBio. 2017;8(4):e00812–7.
5. “Lessells2019.” n.d.